Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice

被引:16
作者
Bilcke, Joke [1 ]
Beutels, Philippe [1 ]
机构
[1] Univ Antwerp CDE, Ctr Hlth Econ Res & Modeling Infect Dis CHERMID, Vaccine & Infect Dis Inst VAXINFECTIO, S-240,Univ Pl 1, B-2610 Antwerp, Belgium
关键词
cost-effective plane; cost-effective frontier; net loss; probabilistic sensitivity analysis; cost-effective threshold; willingness-to-pay threshold; EXPECTED VALUE; ACCEPTABILITY CURVES; SENSITIVITY-ANALYSIS; DECISION RULES; INFORMATION; SAMPLE; MODELS;
D O I
10.1177/0272989X211045070
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This tutorial aims to help make the best available methods for generating and presenting cost-effectiveness results with uncertainty common practice. We believe there is a need for such type of tutorial because some erroneous practices persist (e.g., identifying the cost-effective intervention as the one with the highest probability to be cost-effective), while some of the more advanced methods are hardly used (e.g., the net loss statistic 'NL', expected net loss curves and frontier). The tutorial explains with simple examples the pros and cons of using ICER, incremental net benefit and NL to identify the cost-effective intervention, both with and without uncertainty accounted for probabilistically. A flowchart provides practical guidance on when and how to use ICER, incremental net benefit or NL. Different ways to express and present uncertainty in the results are described, including confidence and credible intervals, the probability that a strategy is cost-effective (as usually shown with cost-effectiveness acceptability curves (CEACs)) and the expected value of perfect information (EVPI). The tutorial clarifies and illustrates why EVPI is the only measure accounting fully for decision uncertainty, and why NL curves and the NL frontier may be preferred over CEACs and other plots for presenting cost-effectiveness results in the context of uncertainty. The easy calculations and a worked-out real-life example will help users to thoroughly understand and correctly interpret key cost-effectiveness results. Examples with mathematical calculations, interpretation, plots and R code are provided.
引用
收藏
页码:421 / 435
页数:15
相关论文
共 41 条
  • [1] "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier
    Alarid-Escudero, Fernando
    Enns, Eva A.
    Kuntz, Karen M.
    Michaud, Tzeyu L.
    Jalal, Hawre
    [J]. VALUE IN HEALTH, 2019, 22 (05) : 611 - 618
  • [2] [Anonymous], 2016, Guideline for Economic Evaluations in Healthcare
  • [3] [Anonymous], 2017, GUID EC EV HLTH TECH
  • [4] Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events
    Basu, Anirban
    Meltzer, David
    [J]. MEDICAL DECISION MAKING, 2018, 38 (04) : 427 - 438
  • [5] Cost-effectiveness thresholds: pros and cons
    Bertram, Melanie Y.
    Lauer, Jeremy A.
    De Joncheere, Kees
    Edejer, Tessa
    Hutubessy, Raymond
    Kieny, Marie-Paule
    Hill, Suzanne R.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2016, 94 (12) : 925 - 930
  • [6] Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
    Bilcke, Joke
    Antillon, Marina
    Pieters, Zoe
    Kuylen, Elise
    Abboud, Linda
    Neuzil, Kathleen M.
    Pollard, Andrew J.
    Paltiel, A. David
    Pitzer, Virginia E.
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (07) : 728 - 739
  • [7] Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models: A Practical Guide
    Bilcke, Joke
    Beutels, Philippe
    Brisson, Marc
    Jit, Mark
    [J]. MEDICAL DECISION MAKING, 2011, 31 (04) : 675 - 692
  • [8] THE CE PLANE - A GRAPHIC REPRESENTATION OF COST-EFFECTIVENESS
    BLACK, WC
    [J]. MEDICAL DECISION MAKING, 1990, 10 (03) : 212 - 214
  • [9] Briggs A., 2006, DECISION MODELLING H
  • [10] Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease
    Briggs, AH
    Goeree, R
    Blackhouse, G
    O'Brien, BJ
    [J]. MEDICAL DECISION MAKING, 2002, 22 (04) : 290 - 308